Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunocore Holdings plc

33.09
+0.90002.80%
Post-market: 33.090.00000.00%16:10 EDT
Volume:280.32K
Turnover:9.20M
Market Cap:1.67B
PE:-81.64
High:33.15
Open:32.68
Low:32.14
Close:32.19
52wk High:39.33
52wk Low:23.15
Shares:50.39M
Float Shares:37.57M
Volume Ratio:1.50
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4053
EPS(LYR):-1.0219
ROE:-5.43%
ROA:-1.69%
PB:4.29
PE(LYR):-32.38

Loading ...

Immunocore Holdings PLC expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
Oct 31

Immunocore Holdings Plc : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $60

THOMSON REUTERS
·
Oct 31

Immunocore’s Brenetafusp: A Promising Study in PRAME-Positive Cancers

TIPRANKS
·
Oct 28

A Look at Immunocore (IMCR) Valuation Following Fresh Analyst Optimism on Positive Anzu-cel Trial Results

Simply Wall St.
·
Oct 26

Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 23

Immunocore Holdings (IMCR) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Oct 15

Immunocore Holdings Head of R&D David M. Berman Reports Disposal of Common Shares

Reuters
·
Oct 03

Immunocore Holdings Coverage Assumed by Guggenheim at Neutral

Dow Jones
·
Sep 18

Immunocore assumed with a Neutral at Guggenheim

TIPRANKS
·
Sep 18

David M. Berman, Head of R&D, Reports Disposal of Common Shares of Immunocore Holdings plc

Reuters
·
Sep 13

Immunocore Holdings plc to Participate in Upcoming Global Healthcare Conferences

Reuters
·
Sep 04

Immunocore Holdings PLC reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Immunocore : Leerink Partners Cuts Target Price to $60.00 From $67.00

THOMSON REUTERS
·
Aug 07

Immunocore Holdings plc Unveils Presentation on Innovative Immunomodulating Medicines Targeting Oncology, Infectious, and Autoimmune Diseases

Reuters
·
Aug 07

BRIEF-Immunocore Reports Second Quarter Financial Results And Provides A Business Update

Reuters
·
Aug 07

Earnings Flash (IMCR) Immunocore Posts Q2 Loss $0.20 a Share, vs. FactSet Est of $0.13 Loss

MT Newswires Live
·
Aug 07

Immunocore Hldgs Q2 EPS $(0.20) Beats $(0.23) Estimate, Sales $97.964M Beat $94.428M Estimate

Benzinga
·
Aug 07

Immunocore : Phase 3 Tebe-Am Trial Remains on Schedule to Complete Enrollment in the First Half of 2026

THOMSON REUTERS
·
Aug 07

Immunocore : Kimmtrak®(Tebentafusp-Tebn) Net Revenues of $98.0 Mln in Q2 2025

THOMSON REUTERS
·
Aug 07

Immunocore Holdings PLC expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
Aug 05